Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvana Novelli

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Mycopathologia|June 22, 2020
Low Rate of Invasive Fungal Infections During Induction and Consolidation Chemotherapy for Adults with De Novo Acute Myeloid Leukemia Without Anti-mold Prophylaxis: Single-Center 2002-2018 Empirical/Pre-emptive ApproachRodrigo Martino, Ana Garrido, Marta Santaliestra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 12, 2013
Impact of hyperferritinemia on the outcome of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for lymphoid malignanciesPere Barba, David Valcárcel, José Antonio Pérez-Simón, et al.
Plos One|June 20, 2018
CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosisMaría José Moreno, Alberto Gallardo, Silvana Novelli, et al.
The Journal of Pathology|September 19, 2014
CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survivalMaría José Moreno, Rosa Bosch, Rebeca Dieguez-Gonzalez, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 10, 2024
Excellent response to anti-CD38 therapy with daratumumab in a patient with severe refractory CANOMADElba Pascual-Goñi, Roger Collet, Clara Tejada-Illa, et al.
Transplantation and Cellular Therapy|April 22, 2023
Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the LiteratureIrene García-Cadenas, Sara Redondo, Albert Esquirol, et al.
Haematologica|October 29, 2013
Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trialJavier Briones, Silvana Novelli, José A García-Marco, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2011
Pretransplantation liver function impacts on the outcome of allogeneic hematopoietic stem cell transplantation: a study of 455 patientsPere Barba, José Luis Piñana, Francesc Fernández-Avilés, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 15, 2017
Do Patients and Physicians Agree When They Assess Quality of Life?Anna Barata, Rodrigo Martino, Ignasi Gich, et al.
European Journal of Haematology|April 14, 2023
Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBISara Redondo, Irene García-Cadenas, Antonio Vila, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Mycopathologia|June 22, 2020
Low Rate of Invasive Fungal Infections During Induction and Consolidation Chemotherapy for Adults with De Novo Acute Myeloid Leukemia Without Anti-mold Prophylaxis: Single-Center 2002-2018 Empirical/Pre-emptive ApproachRodrigo Martino, Ana Garrido, Marta Santaliestra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 12, 2013
Impact of hyperferritinemia on the outcome of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for lymphoid malignanciesPere Barba, David Valcárcel, José Antonio Pérez-Simón, et al.
Plos One|June 20, 2018
CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosisMaría José Moreno, Alberto Gallardo, Silvana Novelli, et al.
The Journal of Pathology|September 19, 2014
CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survivalMaría José Moreno, Rosa Bosch, Rebeca Dieguez-Gonzalez, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 10, 2024
Excellent response to anti-CD38 therapy with daratumumab in a patient with severe refractory CANOMADElba Pascual-Goñi, Roger Collet, Clara Tejada-Illa, et al.
Transplantation and Cellular Therapy|April 22, 2023
Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the LiteratureIrene García-Cadenas, Sara Redondo, Albert Esquirol, et al.
Haematologica|October 29, 2013
Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trialJavier Briones, Silvana Novelli, José A García-Marco, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2011
Pretransplantation liver function impacts on the outcome of allogeneic hematopoietic stem cell transplantation: a study of 455 patientsPere Barba, José Luis Piñana, Francesc Fernández-Avilés, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 15, 2017
Do Patients and Physicians Agree When They Assess Quality of Life?Anna Barata, Rodrigo Martino, Ignasi Gich, et al.
European Journal of Haematology|April 14, 2023
Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBISara Redondo, Irene García-Cadenas, Antonio Vila, et al.
Pageof 7